[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].

نویسندگان

  • Juan Gómez Reino
  • Estíbaliz Loza
  • José Luis Andreu
  • Alejandro Balsa
  • Enrique Batlle
  • Juan D Cañete
  • Eduardo Collantes Estévez
  • Cristina Fernández Carballido
  • José Luis Fernández Sueiro
  • Rosario García de Vicuña
  • Isidoro González-Álvaro
  • Carlos González Fernández
  • Xavier Juanola
  • Luis Francisco Linares
  • José Luis Marenco
  • Emilio Martín Mola
  • Manuel Moreno Ramos
  • Juan Mulero Mendoza
  • Santiago Muñoz Fernández
  • Rubén Queiro
  • Patricia Richi Alberti
  • Jesús Sanz
  • Jesús Tornero Molina
  • Pedro Zarco Montejo
  • Loreto Carmona
چکیده

OBJECTIVE Due to the increasing use of biologic therapy in rheumatic diseases and the importance of its risk management, the Spanish Society of Rheumatology (SER) has promoted the development of recommendations based on the best evidence available. These recommendations should be a reference to rheumatologists and those involved in the treatment of patients who are using, or about to use biologic therapy irrespectively of the rheumatic disease. METHODS Recommendations were developed following a nominal group methodology and based on systematic reviews. The level of evidence and degree of recommendation were classified according to the model proposed by the Center for Evidence Based Medicine at Oxford. The level of agreement was established through a Delphi technique. Evidence from previous consensus and clinical guidelines was used. RESULTS We have produced recommendations on risk management of biologic therapy in rheumatic patients. These recommendations include indication risk management, risk management before the use of biologic therapy, risk management during follow-up, attitude to adverse events, and attitude to special situations. CONCLUSIONS We present the SER recommendations related to biologic therapy risk management.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Preoperative Evaluation and Management of Patients Receiving Biologic Therapies

The preoperative care of patients undergoing orthopedic surgery and treated with biologic agents is of great significance.Perioperative use of biologic agents could lead to such complications as infection and delayed postoperative woundhealing. This narrative review aimed to evaluate the current information on the use of biologic agents in patientsundergoing orthopedic surgery...

متن کامل

[Consensus statement of the Spanish Society of Rheumatology on the management of biologic therapies in psoriatic arthritis].

OBJECTIVE Due to the amount and quality variability regarding the use of biologic therapy (BT) in psoriatic arthritis (PsA) patients, the Spanish Society of Rheumatology (SER) has promoted the generation of recommendations based on the best evidence available. These recommendations should serve as reference to rheumatologists and those involved in the treatment of patients with PsA, who are usi...

متن کامل

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

OBJECTIVE The aim of this study was to establish guidelines for the optimization of biologic therapies for health professionals involved in the management of patients with RA, AS and PsA. METHODS Recommendations were established via consensus by a panel of experts in rheumatology and hospital pharmacy, based on analysis of available scientific evidence obtained from four systematic reviews an...

متن کامل

[2011 Up-date of the consensus statement of the Spanish Society of Rheumatology on osteoporosis].

OBJECTIVE Due to increasing improvement in the diagnosis, evaluation and management of osteoporosis and the development of new tools and drugs, the Spanish Society of Rheumatology (SER) has promoted the development of recommendations based on the best evidence available. These recommendations should be a reference to rheumatologists and other health professionals involved in the treatment of pa...

متن کامل

[Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis].

OBJECTIVE Due to the amount and variability in quality regarding the use of biologic therapy (BT) in patients with spondyloarthritis (SpA), except for psoriatic arthritis (PsA) patients, the Spanish Society of Rheumatology has promoted the generation of recommendations based on the best evidence available. These recommendations should be a reference for rheumatologists and those involved in the...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Reumatologia clinica

دوره 7 5  شماره 

صفحات  -

تاریخ انتشار 2011